[
  {
    "ts": "2026-01-15T15:00:00+00:00",
    "headline": "Henry Schein Enters Exclusive Distribution Agreement for CytoChip’s CLIA-Waived Hematology Analyzer",
    "summary": "IRVINE, Calif., January 15, 2026--Henry Schein, Inc. (Nasdaq: HSIC) has entered into a new exclusive distribution agreement with CytoChip Inc. for its flagship product, the CitoCBC® system, a U.S. Food and Drug Administration (FDA) 510(k)-cleared device. Available now to Henry Schein customers in the United States, the CitoCBC system is the first cartridge-based Complete Blood Count (CBC) system to receive a CLIA Waiver, helping expand access to accurate, lab-quality testing at the point of care",
    "url": "https://finance.yahoo.com/news/henry-schein-enters-exclusive-distribution-150000473.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "97615c32-4542-38d2-a038-9d65f2d1ef11",
      "content": {
        "id": "97615c32-4542-38d2-a038-9d65f2d1ef11",
        "contentType": "STORY",
        "title": "Henry Schein Enters Exclusive Distribution Agreement for CytoChip’s CLIA-Waived Hematology Analyzer",
        "description": "",
        "summary": "IRVINE, Calif., January 15, 2026--Henry Schein, Inc. (Nasdaq: HSIC) has entered into a new exclusive distribution agreement with CytoChip Inc. for its flagship product, the CitoCBC® system, a U.S. Food and Drug Administration (FDA) 510(k)-cleared device. Available now to Henry Schein customers in the United States, the CitoCBC system is the first cartridge-based Complete Blood Count (CBC) system to receive a CLIA Waiver, helping expand access to accurate, lab-quality testing at the point of care",
        "pubDate": "2026-01-15T15:00:00Z",
        "displayTime": "2026-01-15T15:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/d969ef0780a813944f2a09b040a93c55",
          "originalWidth": 480,
          "originalHeight": 320,
          "caption": "CLIA Waived CitoCBC System Designed for On-Site Testing in Urgent Care Centers and Physician Offices.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/yUMEHAi8F7ZGcuiY0UYgXg--~B/aD0zMjA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/d969ef0780a813944f2a09b040a93c55.cf.webp",
              "width": 480,
              "height": 320,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/VLuz8_zBr0LEWUBUUQuN9A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/d969ef0780a813944f2a09b040a93c55.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/henry-schein-enters-exclusive-distribution-150000473.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/henry-schein-enters-exclusive-distribution-150000473.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "HSIC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-15T04:06:20+00:00",
    "headline": "3 Reasons to Sell HSIC and 1 Stock to Buy Instead",
    "summary": "Henry Schein trades at $76.27 per share and has stayed right on track with the overall market, gaining 8% over the last six months. At the same time, the S&P 500 has returned 11.5%.",
    "url": "https://finance.yahoo.com/news/3-reasons-sell-hsic-1-040620121.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "c341cd4c-fd6c-3540-922b-af610c2f04d4",
      "content": {
        "id": "c341cd4c-fd6c-3540-922b-af610c2f04d4",
        "contentType": "STORY",
        "title": "3 Reasons to Sell HSIC and 1 Stock to Buy Instead",
        "description": "",
        "summary": "Henry Schein trades at $76.27 per share and has stayed right on track with the overall market, gaining 8% over the last six months. At the same time, the S&P 500 has returned 11.5%.",
        "pubDate": "2026-01-15T04:06:20Z",
        "displayTime": "2026-01-15T04:06:20Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/be25c9312d8b7f69066e1dc8bc782cb7",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "HSIC Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/FbnTh07KGrlj7634BecIKA--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/be25c9312d8b7f69066e1dc8bc782cb7.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/NQDUkYbPX86B4syA2UewZQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/be25c9312d8b7f69066e1dc8bc782cb7.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/3-reasons-sell-hsic-1-040620121.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/3-reasons-sell-hsic-1-040620121.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "HSIC"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]